Literature DB >> 22645149

Novel anti-inflammatory activity of epoxyazadiradione against macrophage migration inhibitory factor: inhibition of tautomerase and proinflammatory activities of macrophage migration inhibitory factor.

Athar Alam1, Saikat Haldar, Hirekodathakallu V Thulasiram, Rahul Kumar, Manish Goyal, Mohd Shameel Iqbal, Chinmay Pal, Sumanta Dey, Samik Bindu, Souvik Sarkar, Uttam Pal, Nakul C Maiti, Uday Bandyopadhyay.   

Abstract

Macrophage migration inhibitory factor (MIF) is responsible for proinflammatory reactions in various infectious and non-infectious diseases. We have investigated the mechanism of anti-inflammatory activity of epoxyazadiradione, a limonoid purified from neem (Azadirachta indica) fruits, against MIF. Epoxyazadiradione inhibited the tautomerase activity of MIF of both human (huMIF) and malaria parasites (Plasmodium falciparum (PfMIF) and Plasmodium yoelii (PyMIF)) non-competitively in a reversible fashion (K(i), 2.11-5.23 μm). Epoxyazadiradione also significantly inhibited MIF (huMIF, PyMIF, and PfMIF)-mediated proinflammatory activities in RAW 264.7 cells. It prevented MIF-induced macrophage chemotactic migration, NF-κB translocation to the nucleus, up-regulation of inducible nitric-oxide synthase, and nitric oxide production in RAW 264.7 cells. Epoxyazadiradione not only exhibited anti-inflammatory activity in vitro but also in vivo. We tested the anti-inflammatory activity of epoxyazadiradione in vivo after co-administering LPS and MIF in mice to mimic the disease state of sepsis or bacterial infection. Epoxyazadiradione prevented the release of proinflammatory cytokines such as IL-1α, IL-1β, IL-6, and TNF-α when LPS and PyMIF were co-administered to BALB/c mice. The molecular basis of interaction of epoxyazadiradione with MIFs was explored with the help of computational chemistry tools and a biological knowledgebase. Docking simulation indicated that the binding was highly specific and allosteric in nature. The well known MIF inhibitor (S,R)-3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazole acetic acid methyl ester (ISO-1) inhibited huMIF but not MIF of parasitic origin. In contrast, epoxyazadiradione inhibited both huMIF and plasmodial MIF, thus bearing an immense therapeutic potential against proinflammatory reactions induced by MIF of both malaria parasites and human.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22645149      PMCID: PMC3397911          DOI: 10.1074/jbc.M112.341321

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  87 in total

1.  An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer.

Authors:  Oriana Hawkins; Bhavna Verma; Stanley Lightfoot; Rinki Jain; Amit Rawat; Sandy McNair; Shannon Caseltine; Aleksandar Mojsilovic; Priyanka Gupta; Francisca Neethling; Othon Almanza; William Dooley; William Hildebrand; Jon Weidanz
Journal:  J Immunol       Date:  2011-04-22       Impact factor: 5.422

Review 2.  Macrophage migration inhibitory factor: a critical component of autoimmune inflammatory diseases.

Authors:  Richard Bucala; Elias Lolis
Journal:  Drug News Perspect       Date:  2005-09

3.  Activity-guided isolation and identification of Azadirachta indica bark extract constituents which specifically inhibit chemiluminescence production by activated human polymorphonuclear leukocytes.

Authors:  J M van der Nat; W G van der Sluis; L A 't Hart; H Van Dijk; K T de Silva; R P Labadie
Journal:  Planta Med       Date:  1991-02       Impact factor: 3.352

4.  Synthesis and bio-evaluation of human macrophage migration inhibitory factor inhibitor to develop anti-inflammatory agent.

Authors:  Athar Alam; Chinmay Pal; Manish Goyal; Milan Kumar Kundu; Rahul Kumar; Mohd Shameel Iqbal; Sumanta Dey; Samik Bindu; Souvik Sarkar; Uttam Pal; Nakul C Maiti; Susanta Adhikari; Uday Bandyopadhyay
Journal:  Bioorg Med Chem       Date:  2011-10-24       Impact factor: 3.641

Review 5.  Macrophage migration inhibitory factor and its role in autoimmune diseases.

Authors:  Claudia M Denkinger; Christine Metz; Günter Fingerle-Rowson; Michael D Denkinger; Thomas Forsthuber
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2004 Nov-Dec       Impact factor: 4.291

6.  Molecular expression and characterization of a homologue of host cytokine macrophage migration inhibitory factor from Trichinella spp.

Authors:  Z Wu; T Boonmars; I Nagano; T Nakada; Y Takahashi
Journal:  J Parasitol       Date:  2003-06       Impact factor: 1.276

7.  Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival.

Authors:  Diana Starlets; Yael Gore; Inbal Binsky; Michal Haran; Nurit Harpaz; Lev Shvidel; Shirly Becker-Herman; Alain Berrebi; Idit Shachar
Journal:  Blood       Date:  2006-02-16       Impact factor: 22.113

8.  Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.

Authors:  Stanislava Stosic-Grujicic; Ivana Stojanovic; Danijela Maksimovic-Ivanic; Miljana Momcilovic; Dusan Popadic; Ljubica Harhaji; Djordje Miljkovic; Christine Metz; Katia Mangano; Gianpaolo Papaccio; Yousef Al-Abed; Ferdinando Nicoletti
Journal:  J Cell Physiol       Date:  2008-06       Impact factor: 6.384

9.  Functional characterization of the Plasmodium falciparum and P. berghei homologues of macrophage migration inhibitory factor.

Authors:  Kevin D Augustijn; Robert Kleemann; Joanne Thompson; Teake Kooistra; Carina E Crawford; Sarah E Reece; Arnab Pain; Arjan H G Siebum; Chris J Janse; Andrew P Waters
Journal:  Infect Immun       Date:  2006-12-11       Impact factor: 3.441

10.  A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia.

Authors:  Michael A McDevitt; Jianlin Xie; Shanmugasundaram Ganapathy-Kanniappan; Ganapathy Shanmugasundaram; Jason Griffith; Aihua Liu; Courtney McDonald; Philip Thuma; Victor R Gordeuk; Christine N Metz; Robert Mitchell; Jeffrey Keefer; John David; Lin Leng; Richard Bucala
Journal:  J Exp Med       Date:  2006-04-24       Impact factor: 14.307

View more
  26 in total

1.  Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor.

Authors:  Vinay Trivedi-Parmar; William L Jorgensen
Journal:  J Med Chem       Date:  2018-06-04       Impact factor: 7.446

2.  Neem (Azadirachta indica): prehistory to contemporary medicinal uses to humankind.

Authors:  Venugopalan Santhosh Kumar; Visweswaran Navaratnam
Journal:  Asian Pac J Trop Biomed       Date:  2013-07

3.  The use of an extract of Hypericum perforatum and Azadirachta indica in advanced diabetic foot: an unexpected outcome.

Authors:  Maria Letizia Iabichella
Journal:  BMJ Case Rep       Date:  2013-02-13

4.  Ultra-high performance liquid chromatography Q-Orbitrap MS/MS-based profiling and quantification of limonoids in Meliaceae plants.

Authors:  Fayaj A Mulani; Sharvani S Nandikol; Jagadeesh S Kajjihundi; Niranjana Pathappa; Sharanappa Puttappa; Hirekodathakallu V Thulasiram
Journal:  Anal Bioanal Chem       Date:  2022-06-21       Impact factor: 4.478

5.  The macrophage migration inhibitory factor homolog of Entamoeba histolytica binds to and immunomodulates host macrophages.

Authors:  Shannon N Moonah; Mayuresh M Abhyankar; Rashidul Haque; William A Petri
Journal:  Infect Immun       Date:  2014-05-12       Impact factor: 3.441

6.  Virtual screening and optimization yield low-nanomolar inhibitors of the tautomerase activity of Plasmodium falciparum macrophage migration inhibitory factor.

Authors:  Markus K Dahlgren; Alvaro Baeza Garcia; Alissa A Hare; Julian Tirado-Rives; Lin Leng; Richard Bucala; William L Jorgensen
Journal:  J Med Chem       Date:  2012-10-26       Impact factor: 7.446

Review 7.  PubChem applications in drug discovery: a bibliometric analysis.

Authors:  Tiejun Cheng; Yongmei Pan; Ming Hao; Yanli Wang; Stephen H Bryant
Journal:  Drug Discov Today       Date:  2014-08-27       Impact factor: 7.851

Review 8.  Exploring the role of Azadirachta indica (neem) and its active compounds in the regulation of biological pathways: an update on molecular approach.

Authors:  Subendu Sarkar; Rajender Pal Singh; Gorachand Bhattacharya
Journal:  3 Biotech       Date:  2021-03-20       Impact factor: 2.406

9.  Binding interaction of a novel fluorophore with serum albumins: steady state fluorescence perturbation and molecular modeling analysis.

Authors:  Uttam Pal; Sumit Kumar Pramanik; Baisali Bhattacharya; Biswadip Banerji; Nakul Chandra Maiti
Journal:  Springerplus       Date:  2015-09-24

10.  2,2'-diphenyl-3,3'-diindolylmethane: a potent compound induces apoptosis in breast cancer cells by inhibiting EGFR pathway.

Authors:  Arijit Bhowmik; Nilanjana Das; Uttam Pal; Madhumita Mandal; Seemana Bhattacharya; Moumita Sarkar; Parasuraman Jaisankar; Nakul C Maiti; Mrinal K Ghosh
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.